Literature DB >> 22869395

Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma.

Lorenz Kuske1, Armand Mensen, Beat Müllhaupt, Francesco Negro, David Semela, Darius Moradpour, Pierre Jean Malé, Markus H Heim, Raffaele Malinverni, Andreas Cerny, Jean-François Dufour.   

Abstract

BACKGROUND AND AIM: Hepatocellular carcinoma (HCC) is the most frequent form of primary liver cancer and chronic infection with hepatitis C virus is one of the main risk factors for HCC. This study analyses the characteristics of the patients with chronic hepatitis C participating in the Swiss Hepatitis C Cohort Study who developed HCC.
METHODS: Analysis of the database of the Swiss Hepatitis C Cohort Study, a multicentre study that is being carried out in eight major Swiss hospitals since the year 2000. Patients with chronic hepatitis C and HCC were regrouped and compared to the patients without HCC.
RESULTS: Among the 3,390 patients of the cohort, 130 developed an HCC. Age was one of the determining factors. Cirrhosis and its complications ascites and porto-systemic encephalopathy were associated with HCC. Males presented a higher risk for HCC than females. Alcohol consumption was associated with HCC. Diabetes mellitus was an important risk factor, especially in patients with low fibrosis. Patients with Hepatitis C genotype 2 had significantly less HCC than patients with other genotypes. A low socioeconomic status (income, education, profession) was associated with HCC.
CONCLUSIONS: Beside the expected characteristics (age, gender, cirrhosis, alcohol), these data stress the role of diabetes mellitus and reveal the importance of low socioeconomic status as a risk factor for HCC in Swiss patients infected with hepatitis C virus. This vulnerable population should be closely monitored.

Entities:  

Mesh:

Year:  2012        PMID: 22869395     DOI: 10.4414/smw.2012.13651

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  5 in total

1.  Therapeutic actions of melatonin on gastrointestinal cancer development and progression.

Authors:  Rachael Glenister; Kelly McDaniel; Heather Francis; Julie Venter; Kendal Jensen; Giuseppina Dusio; Eugenio Gaudio; Shannon Glaser; Fanyin Meng; Gianfranco Alpini
Journal:  Transl Gastrointest Cancer       Date:  2013-01-01

2.  Transforming growth factor-β1 and lysophosphatidic acid activate integrin β6 gene promoter in Hep-3B cells.

Authors:  Ruirui Xu; Mingyan Xu; Yucai Fu; Xiaoling Deng; Hui Han; Xihe Chen; Wenjing He; Gengzhen Chen
Journal:  Oncol Lett       Date:  2018-05-08       Impact factor: 2.967

Review 3.  Could metabolic syndrome lead to hepatocarcinoma via non-alcoholic fatty liver disease?

Authors:  Antonella Scalera; Giovanni Tarantino
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

4.  The impact of socioeconomic status on outcomes in hepatocellular carcinoma: Inferences from primary insurance.

Authors:  Cortlandt M Sellers; Johannes Uhlig; Johannes M Ludwig; Tamar Taddei; Stacey M Stein; Joseph K Lim; Hyun S Kim
Journal:  Cancer Med       Date:  2019-08-22       Impact factor: 4.452

5.  The association between micro-RNA gene polymorphisms and the development of hepatocellular carcinoma in Egyptian patients.

Authors:  Maha M Allam; Karema A Diab; Fatma O Khalil; Fatma A Khalaf; Mohamed Abdel-Samiee; Nashwa Sheble; Mohamed A Eljaky; Essam Zayed; Warda Othman; Mervat Abd-Elkreem; Eman Abdelsameea
Journal:  Arch Med Sci       Date:  2021-03-18       Impact factor: 3.318

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.